Advertisement
News
Subscribe to MDT Magazine News

Antigenics advances herpes vaccine

July 27, 2010 10:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Antigenics says it has achieved positive results in an early stage human trial for a potential herpes vaccine.

Minn.-based 3M settles Wis. air-pollution charges

July 27, 2010 9:45 am | by The Associated Press | Comments

Wisconsin officials say 3M Co. has agreed to pay $150,000 to settle allegations of air-pollution violations at its Prairie du Chien (doo SHEEN') facility.The state attorney general's office said Tuesday the company had modified an air-pollution source without a required permit. The office also...

Safety Tips for Laboratorians: How Laboratorians Can Safely Calculate Workload for FDA-Approved Semi-Automated Gynecologic Cytology Screening Devices

July 27, 2010 9:36 am | by U.S. Food & Drug Administration | Comments

The purpose of this communication is to clarify for laboratories how workload should be calculated when using currently FDA-approved semi-automated gynecologic cytology screening devices. This communication is intended for cytotechnologists, technical...

Advertisement

Foundation Venture Capital Group Sells Interest in Longevica Pharmaceuticals

July 27, 2010 9:35 am | by Bio-Medicine.Org | Comments

NEW BRUNSWICK, N.J. , July 27 /- James M. Golubieski , president of Foundation Venture Capital Group, LLC, (FVCG) a New Jersey Health Foundation/Foundation of UMDNJ affiliate, announced today that it has sold its equity interest in Longevica Pharmaceuticals, Inc., to Rostock International...

TOPICS:

Axela acquires Xceed Molecular

July 27, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Xceed Molecular, based in Toronto and Wellesley, has been acquired by Anaheim, Calif., based Axela Inc. which plans to provide clinical researchers with a suite of products for enhanced analysis of proteins, pathogens, DNA and RNA.

TOPICS:

BD Board of Directors Elects Christopher Jones

July 27, 2010 8:34 am | by Becton, Dickinson and Company | Comments

(July 26, 2010) -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, announced today that it has elected Christopher Jones to its Board of Directors, effective today.  Mr. Jones, 55, is the former Chief Executive Of

TOPICS:

Mindray to Attend the 2010 American Association for Clinical Chemistry Conference

July 27, 2010 8:34 am | by Bio-Medicine.Org | Comments

SHENZHEN, China , July 27 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced it will attend the 2010 American Association for Clinical Chemistry (AACC) conference in...

TOPICS:

Moffitt Cancer Center and CvergenX, Inc. Sign Licensing Agreement

July 27, 2010 8:33 am | by Bio-Medicine.Org | Comments

TAMPA, Fla. , July 27 /- Moffitt Cancer Center and CvergenX, Inc. , announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™....

TOPICS:
Advertisement

O.I. Corporation Announces Third Quarter Dividend

July 27, 2010 7:45 am | by The Associated Press | Comments

O.I. Corporation (NASDAQ: OICO) today announced that its Board of Directors declared a quarterly cash dividend of $0.05 per common share payable on August 30, 2010 to shareholders of record at the close of business on August 13, 2010.About O.I. Corporation:O.I. Corporation, dba OI Analytical,...

Covidien closes $250M tender offer for Somanetics

July 27, 2010 7:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Covidien plc reports it has completed its tender offer through a subsidiary, Covidien DE Corp., to purchase all of the outstanding common shares of Somanetics Corp. of Michigan in a deal that would be worth about $250 million.

Joint Statement on Wireless Medical Devices - U.S. Food and Drug Administration, Federal Communications Commission

July 27, 2010 7:30 am | by U.S. Food & Drug Administration | Comments

Innovation in broadband and wireless-enabled medical devices holds significant promise for enhancing health and reducing the costs of health care for all Americans. Examples include wireless sensors that remotely monitor heart rhythm and portable...

TOPICS:

Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies

July 27, 2010 6:32 am | by Bio-Medicine.Org | Comments

BOZEN, SUD-TIROL, Italy , July 27, 2010 /- Health Robotics announced that it has reached final agreements to acquire all assets from Italy -based MEDarchiver S.r.l. and Biomedical Technology Consulting S.r.l., merging these companies' employees and operations, re-entering direct sales...

TOPICS:

Cynosure revenue is up, losses down

July 27, 2010 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Westford-based Cynosure Inc., a maker of lasers used for cosmetic procedures and dermatology-related applications, reported a modest growth in second quarter revenue, but a significant cut in Q2 losses compared to 2009.

HealthSouth investors to get settlement cash

July 27, 2010 4:45 am | by The Associated Press | Comments

The Securities and Exchange Commission says $106 million that HealthSouth Corp. agreed to pay investors is ready for distribution to those who qualify.The payout stems from of an SEC lawsuit in 2003. Birmingham-based hospital operator HealthSouth agreed to settle the suit in 2005 by paying $100...

Omeros Enrolls First Patient in Phase 2b Clinical Trial Evaluating OMS302 in Patients Undergoing Cataract Surgery

July 27, 2010 4:35 am | by Bio-Medicine.Org | Comments

SEATTLE , July 27 /- Omeros Corporation (Nasdaq: OMER ), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading